A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group

By Pautier P.   Floquet A.   Gladieff L.   Bompas E.   Ray-Coquard I.   Piperno-Neumann S.   Selle F.   Guillemet C.   Weber B.   Largillier R.   Bertucci F.   Opinel P.   Duffaud F.   Reynaud-Bougnoux A.   Delcambre C.   Isambert N.   Kerbrat P.   Netter-Pinon G.   Pinto N.   Duvillard P.   Haie-Meder C.   Lhomm C.   Rey A.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1099-1104

Oxford University Press

Access to resources Recommend Favorite

Efficacy and safety of single agent capecitabine in pretreated metastatic breast cancer patients from the French compassionate use program

By Pierga J. Y.   Fumoleau P.   Brewer Y.   Zelek L.   Martin D.   Turpin F. L.   Goudier M. J.   Gil-delgado M.   Baticle J. L.   Namer M.   Chollet P.   Sutherland W.   Barats J. C.  

Breast Cancer Research and Treatment, Vol. 88, Iss. 2, 2004-11 ,pp. : 117-129

Springer Publishing Company

Access to resources Recommend Favorite

Chronic Administration of Single-Agent Paclitaxel in Gynecologic Malignancies

By Rohl J.   Kushner D.   Markman M.  

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 201-205

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of probiotics as adjuvant agents for Helicobacter pylori infection: A metaanalysis

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 3, 2015-01 ,pp. : 707-716

Spandidos Publications

Access to resources Recommend Favorite

A prospective study of pre-operative chemotherapy with single agent ifosfamide for malignant fibrous histiocytoma of bone (MFH-B)

By McTiernan Anne  

Sarcoma, Vol. 8, Iss. 2-3, 2004-06 ,pp. : 77-82

Informa Healthcare

Access to resources Recommend Favorite